請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89712完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 顏若芳 | zh_TW |
| dc.contributor.advisor | Ruoh-Fang Yen | en |
| dc.contributor.author | 蔡雅琴 | zh_TW |
| dc.contributor.author | Ya-Chin Tsai | en |
| dc.date.accessioned | 2023-09-18T16:06:17Z | - |
| dc.date.available | 2023-11-09 | - |
| dc.date.copyright | 2023-09-18 | - |
| dc.date.issued | 2023 | - |
| dc.date.submitted | 2023-07-02 | - |
| dc.identifier.citation | 1. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167-176. doi: 10.1016/s1474-4422(09)70340-0
2. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450-1460. doi: 10.1056/nejm200105103441907 3. Tsai HH, Tsai LK, Chen YF, Tang SC, Lee BC, Yen RF, Jeng JS. Correlation of Cerebral Microbleed Distribution to Amyloid Burden in Patients with Primary Intracerebral Hemorrhage. Sci Rep. 2017;7:44715. doi: 10.1038/srep44715 4. Pasi M, Sugita L, Xiong L, Charidimou A, Boulouis G, Pongpitakmetha T, Singh S, Kourkoulis C, Schwab K, Greenberg SM, et al. Association of Cerebral Small Vessel Disease and Cognitive Decline After Intracerebral Hemorrhage. Neurology. 2021;96:e182-e192. doi: 10.1212/WNL.0000000000011050 5. Chojdak-Łukasiewicz J, Dziadkowiak E, Zimny A, Paradowski B. Cerebral small vessel disease: A review. Adv Clin Exp Med. 2021;30:349-356. doi: 10.17219/acem/131216 6. Garcia JH, Ho KL. Pathology of hypertensive arteriopathy. Neurosurg Clin N Am. 1992;3:497-507. 7. Charidimou A, Boulouis G, Frosch MP, Baron J-C, Pasi M, Albucher JF, Banerjee G, Barbato C, Bonneville F, Brandner S, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study. The Lancet Neurology. 2022;21:714-725. doi: 10.1016/s1474-4422(22)00208-3 8. Potter T, Lioutas VA, Tano M, Pan A, Meeks J, Woo D, Seshadri S, Selim M, Vahidy F. Cognitive Impairment After Intracerebral Hemorrhage: A Systematic Review of Current Evidence and Knowledge Gaps. Front Neurol. 2021;12:716632. doi: 10.3389/fneur.2021.716632 9. Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke Vasc Neurol. 2016;1:83-92. doi: 10.1136/svn-2016-000035 10. Benedictus MR, Hochart A, Rossi C, Boulouis G, Henon H, van der Flier WM, Cordonnier C. Prognostic Factors for Cognitive Decline After Intracerebral Hemorrhage. Stroke. 2015;46:2773-2778. doi: 10.1161/STROKEAHA.115.010200 11. Moulin S, Labreuche J, Bombois S, Rossi C, Boulouis G, Hénon H, Duhamel A, Leys D, Cordonnier C. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. The Lancet Neurology. 2016;15:820-829. doi: 10.1016/s1474-4422(16)00130-7 12. Catafau AM, Bullich S. Amyloid PET imaging: applications beyond Alzheimer's disease. Clin Transl Imaging. 2015;3:39-55. doi: 10.1007/s40336-014-0098-3 13. Tsai HH, Pasi M, Tsai LK, Huang CC, Chen YF, Lee BC, Yen RF, Gurol ME, Jeng JS. Centrum Semiovale Perivascular Space and Amyloid Deposition in Spontaneous Intracerebral Hemorrhage. Stroke. 2021;52:2356-2362. doi: 10.1161/STROKEAHA.120.032139 14. Tsai HH, Pasi M, Tsai LK, Chen YF, Lee BC, Tang SC, Fotiadis P, Huang CY, Yen RF, Jeng JS, et al. Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study. Neurology. 2019;92:e774-e781. doi: 10.1212/WNL.0000000000006953 15. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet Neurology. 2013;12:822-838. doi: 10.1016/s1474-4422(13)70124-8 16. Charidimou A, Boulouis G, Roongpiboonsopit D, Auriel E, Pasi M, Haley K, van Etten ES, Martinez-Ramirez S, Ayres A, Vashkevich A, et al. Cortical superficial siderosis multifocality in cerebral amyloid angiopathy: A prospective study. Neurology. 2017;89:2128-2135. doi: 10.1212/wnl.0000000000004665 17. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149:351-356. doi: 10.2214/ajr.149.2.351 18. Kim KW, MacFall JR, Payne ME. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry. 2008;64:273-280. doi: 10.1016/j.biopsych.2008.03.024 19. Pasi M, Boulouis G, Fotiadis P, Auriel E, Charidimou A, Haley K, Ayres A, Schwab KM, Goldstein JN, Rosand J, et al. Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease. Neurology. 2017;88:2162-2168. doi: 10.1212/wnl.0000000000004007 20. Tsai HH, Pasi M, Tsai LK, Chen YF, Lee BC, Tang SC, Fotiadis P, Huang CY, Yen RF, Gurol ME, et al. Distribution of Lacunar Infarcts in Asians With Intracerebral Hemorrhage: A Magnetic Resonance Imaging and Amyloid Positron Emission Tomography Study. Stroke. 2018;49:1515-1517. doi: 10.1161/STROKEAHA.118.021539 21. Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41:450-454. doi: 10.1161/STROKEAHA.109.564914 22. Tsai HH, Pasi M, Tsai LK, Chen YF, Chen YW, Tang SC, Gurol ME, Yen RF, Jeng JS. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020;51:202-208. doi: 10.1161/STROKEAHA.119.026235 23. Xiong L, Charidimou A, Pasi M, Boulouis G, Pongpitakmetha T, Schirmer MD, Singh S, Benson E, Gurol EM, Rosand J, et al. Predictors for Late Post-Intracerebral Hemorrhage Dementia in Patients with Probable Cerebral Amyloid Angiopathy. J Alzheimers Dis. 2019;71:435-442. doi: 10.3233/JAD-190346 24. Biffi A, Bailey D, Anderson CD, Ayres AM, Gurol EM, Greenberg SM, Rosand J, Viswanathan A. Risk Factors Associated With Early vs Delayed Dementia After Intracerebral Hemorrhage. JAMA Neurol. 2016;73:969-976. doi: 10.1001/jamaneurol.2016.0955 25. Vasilevko V, Passos GF, Quiring D, Head E, Kim RC, Fisher M, Cribbs DH. Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy. Ann N Y Acad Sci. 2010;1207:58-70. doi: 10.1111/j.1749-6632.2010.05786.x 26. Smith EE. Cerebral amyloid angiopathy as a cause of neurodegeneration. J Neurochem. 2018;144:651-658. doi: 10.1111/jnc.14157 27. Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015;85:1930-1936. doi: 10.1212/wnl.0000000000002175 28. Gokcal E, Horn MJ, Becker JA, Das AS, Schwab K, Biffi A, Rost N, Rosand J, Viswanathan A, Polimeni JR, et al. Effect of vascular amyloid on white matter disease is mediated by vascular dysfunction in cerebral amyloid angiopathy. J Cereb Blood Flow Metab. 2022;42:1272-1281. doi: 10.1177/0271678X221076571 29. Frings L, Hellwig S, Bormann T, Spehl TS, Buchert R, Meyer PT. Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population. Eur J Nucl Med Mol Imaging. 2018;45:1442-1448. doi: 10.1007/s00259-018-3983-6 30. Trzepacz PT, Yu P, Sun J, Schuh K, Case M, Witte MM, Hochstetler H, Hake A, Alzheimer's Disease Neuroimaging I. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Neurobiol Aging. 2014;35:143-151. doi: 10.1016/j.neurobiolaging.2013.06.018 31. Liu W, Wong A, Au L, Yang J, Wang Z, Leung EY, Chen S, Ho CL, Mok VC. Influence of Amyloid-beta on Cognitive Decline After Stroke/Transient Ischemic Attack: Three-Year Longitudinal Study. Stroke. 2015;46:3074-3080. doi: 10.1161/STROKEAHA.115.010449 32. Zhang Q, Zhao X, Lei P, Kung HF, Yang Z, Zhu L, Wang S, Zhu H, Meng X, Duan Y, et al. Evaluating [(68)Ga]Ga-p14-032 as a Novel PET Tracer for Diagnosis Cerebral Amyloid Angiopathy. Front Neurol. 2021;12:702185. doi: 10.3389/fneur.2021.702185 | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89712 | - |
| dc.description.abstract | 認知功能障礙,範疇包括輕微認知功能障礙和癡呆,是出血性腦中風存活者一個重要的研究課題。大約八成的出血性腦中風被診斷為原發性,其中以腦部小血管疾病為最常見的病因。現有證據顯示既有的微血管病變和累積的腦部實質傷害促進了出血性腦中風存活者長期後的認知功能障礙。我們這篇前瞻性的研究,招募了尚未癡呆的出血性腦中風存活者,讓他們接受 C-11 PiB正子掃描,以比較類澱粉掃描結果陽性和陰性病患長期的認知功能情形。我們的結果顯示,類澱粉掃描陽性結果和長期後的認知功能障礙有獨立相關性。我們的發現暗示著,腦部的類澱粉,不管是腦血管的或是腦實質的,都是出血性腦中風存活者長期後是否會發生認知功能障礙,一個重要的影響因子。 | zh_TW |
| dc.description.abstract | Cognitive impairment, including mild cognitive impairment and dementia, is a major issue and causes disabilities in ICH survivors. About 80% of ICH patients are diagnosed as primary ICH, with cerebral small vessel disease (CSVD) as the most common etiology. Current evidence suggests that pre-existing underlying microangiopathy and the related accumulation of parenchymal injuries contribute substantially to the long-term cognitive impairment in survivors of primary ICH. In this prospective cohort study, we included survivors of primary ICH without overt dementia who received C-11 PIB PET scan to compare the longitudinal cognitive outcomes of patients with positive and negative amyloid scans. We showed that a positive amyloid scan was independently associated with a 33% incidence per person-years and a 16-fold higher risk of dementia conversion. We also showed that a positive amyloid scan was independently associated with a 59% incidence per person-years and a 6-fold higher risk of cognitive decline. Our findings implicate that cerebral amyloid, which can be related to vascular or parenchymal β-amyloid, is an important factor for cognitive decline in patients harboring hemorrhagic CSVD. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-09-18T16:06:17Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2023-09-18T16:06:17Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii 英文摘要 iv 目錄 v 圖目錄 viii 表目錄 ix 第一章 緒論 (Introduction) 1 1.1 Primary intracerebral hemorrhage 1 1.2 Long-term cognitive impairment after primary intracerebral hemorrhage 2 1.3 Cerebral amyloid deposition and long-term cognitive impairment after primary intracerebral hemorrhage 3 1.4 C-11 Pittsburgh compound B (PiB) positron emission tomography (PET) 4 1.5 Research hypothesis and major aim 4 第二章 研究材料與方法 (Materials and Methods) 6 2.1 Patient enrollment and demographic characteristics acquisition 6 2.2 MRI acquisition and analysis 7 2.3 PET acquisition and analysis 9 2.4 Baseline and follow-up cognition evaluation 10 2.5 Statistical analysis 11 第三章 結果 (Results) 13 3.1 Patient characteristics 13 3.2 Markers and long-term cognitive impairment 14 3.3 PiB and long-term cognitive impairment 15 第四章 討論 (Discussion) 16 4.1 MRI neuroimaging markers of CSVD parenchymal injuries 16 4.2 Cerebral amyloid load 16 4.3 Cerebral amyloid is an important factor for cognitive decline in patients after primary ICH 16 4.4 Cerebral amyloid is a more important factor than MRI markers 17 4.5 The first study specifically demonstrated the relationship between cerebral amyloid and cognitive outcomes in survivors of ICH 18 4.6 Limitation of the study 19 4.6.1 Selection bias 19 4.6.2 No precise epidemiological data on post-ICH cognitive impairment 19 4.6.3 Lack of detailed neuropsychological assessment 20 4.6.4 Inability to differentiate vascular from parenchymal retention 20 4.6.5 Small sample size 20 第五章 結論 (Conclusion) 21 第六章 參考文獻 (Reference) 22 第七章 附錄 (Appendix) 29 | - |
| dc.language.iso | en | - |
| dc.subject | 出血性腦中風 | zh_TW |
| dc.subject | 類澱粉掃描 | zh_TW |
| dc.subject | 腦部小血管疾病 | zh_TW |
| dc.subject | 癡呆 | zh_TW |
| dc.subject | 認知功能障礙 | zh_TW |
| dc.subject | Cerebral small vessel disease | en |
| dc.subject | Amyloid scan | en |
| dc.subject | Dementia | en |
| dc.subject | Intracerebral hemorrhage | en |
| dc.subject | Cognitive impairment | en |
| dc.title | C-11 PiB正子造影和自發性腦出血中風後長期認知障礙之相關性研究 | zh_TW |
| dc.title | Association between C-11 Pittsburgh compound B PET and long-term cognitive impairment after primary intracerebral hemorrhage | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 111-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 吳文超;蔡欣熹 | zh_TW |
| dc.contributor.oralexamcommittee | Wen-Chau Wu;Hsin-Hsi Tsai | en |
| dc.subject.keyword | 出血性腦中風,腦部小血管疾病,類澱粉掃描,癡呆,認知功能障礙, | zh_TW |
| dc.subject.keyword | Intracerebral hemorrhage,Cerebral small vessel disease,Amyloid scan,Dementia,Cognitive impairment, | en |
| dc.relation.page | 34 | - |
| dc.identifier.doi | 10.6342/NTU202301304 | - |
| dc.rights.note | 未授權 | - |
| dc.date.accepted | 2023-07-03 | - |
| dc.contributor.author-college | 醫學院 | - |
| dc.contributor.author-dept | 臨床醫學研究所 | - |
| 顯示於系所單位: | 臨床醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-111-2.pdf 未授權公開取用 | 882.33 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
